Vorsitz/Chair: Clemens Jilek (Berg), Vanessa Sciacca (Bad Oeynhausen)
Agenda
08:30
(V46)
Role of BMI on radiation dose in patients undergoing pulmonary vein isolation by pulsed field, cryoballoon and high-power-short-duration radiofrequency ablation
J. Kupusovic (Frankfurt am Main)
Zum Abstract
08:37
Diskussion
08:41
(V47)
Role of age in pulmonary vein isolation procedures in the new pulsed-field-ablation era - a single center experience.
A. Falagkari (Frankfurt am Main)
Zum Abstract
08:48
Diskussion
08:52
(V48)
Initial experiences on acute efficacy and safety of pulmonary vein isolation and left atrial roof ablation in patients with atrial fibrillation using a novel pulsed field ablation loop catheter
J. Yogarajah (Bad Nauheim)
Zum Abstract
08:59
Diskussion
09:03
(V49)
Safety and impact on renal function of the novel olive strategy with the pentaspline pulsed field catheter
J. A. Kheir (Frankfurt am Main)
Zum Abstract
09:10
Diskussion
09:14
(V50)
The olive strategy: a novel ablation protocol for pulmonary vein isolation with the pentaspline pulsed field catheter
D. Schaack (Frankfurt am Main)
Zum Abstract
09:21
Diskussion
09:25
(V51)
Effektivität und Sicherheit der pulsed field Ablation im Vergleich zur Kryoballonablation in der Behandlung von Vorhofflimmern - Eine Metaanalyse
I. M. Rudolph (München)
Zum Abstract
09:32
Diskussion
09:36
(V52)
A Comparison of Very High-Power Short-Duration Versus High-Power Short-Duration Ablation in Pulmonary Vein Isolation for Atrial Fibrillation
P. Biehler (Aalen)
Zum Abstract
09:43
Diskussion
09:47
(V53)
Impact of Mitral Regurgitation on Outcomes of High-Power Short-Duration Pulmonary Vein Isolation in Patients with Atrial Fibrillation